OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Biomarkers provide a dynamic and powerful approach to understanding the spectrum of diseases from the earliest manifestations to the terminal stages. A recently published framework for the diagnosis of Alzheimer’s Disease (AD) in research studies would allow diagnosis on the sole basis of two biomarkers (-amyloid and tau). This revision will have substantial implications for future Alzheimer’s research. We will discuss the conditions that need to be met (validity, reliability, innovation) for this new diagnostic framework to foster identification of effective strategies to prevent or treat AD.
